Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
07/17/2008 | US20080171754 Certain pyrazoline derivatives with kinase inhibitory activity |
07/17/2008 | US20080171732 e.g. ethyl6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-5-cyano-2-methoxynicotinate; reversible and selective purinergic receptor antagonist; anticoagulant; cardiovascular diseases; platelet aggregation, thrombotic occlusion, myocardial infarction and unstable angina |
07/17/2008 | US20080171692 Substituted amides |
07/17/2008 | DE19618586B4 Monoazo-Dispersionsfarbstoffe Monoazo disperse dyes |
07/17/2008 | CA2674647A1 Chemical compounds 637 |
07/17/2008 | CA2674644A1 Sulfonamide derivatives as chymase inhibitors |
07/16/2008 | EP1944308A1 Process for production of ortho-metallized 1:3 complex of iridium with homoligand |
07/16/2008 | EP1944304A1 Novel sustituted 1H-dihydropyrazoles, their preparation and use |
07/16/2008 | EP1944289A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
07/16/2008 | EP1943233A2 Compounds and compositions for protein kinase inhbitors |
07/16/2008 | EP1943213A2 Ppar modulating biaromatic compounds |
07/16/2008 | EP1943209A1 A process for preparing beta-ketoester compounds |
07/16/2008 | EP1942899A2 Mitotic kinesin inhibitors |
07/16/2008 | EP1392655B1 Potassium channel openers |
07/16/2008 | EP1165551B1 C10 carbamoyloxy substituted taxanes as antitumor agents |
07/16/2008 | CN101223141A Certain substituted amides, method of making, and method of use thereof |
07/16/2008 | CN101223130A Glutamate aggrecanase inhibitors |
07/16/2008 | CN101220024A A set of anti-cancer compound restraining kinase |
07/16/2008 | CN101219990A Method for distillation of front cut fraction of trichloropyridine sodium alcoholate |
07/16/2008 | CN101219989A 2-phenylpyridine derivant with triphenylamine and carbazole as modification group and synthesizing method thereof |
07/16/2008 | CN101219988A Synthesis of 4,4í»disubstituted-2,2í»-dipyridine |
07/16/2008 | CN101219987A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same |
07/16/2008 | CN100402525C Pyridine derivatives as fungicidal compounds |
07/16/2008 | CN100402499C 2-iminopyrrolidine derivatives |
07/15/2008 | US7399878 Pharmaceutical compounds |
07/15/2008 | US7399866 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
07/15/2008 | US7399788 N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them |
07/15/2008 | US7399780 pyridin-2-yl-1H-indole or pyrimidin-4-yl-1H-indole derivatives; enzyme inhibitor of glycogen synthase kinase-3; treating dementia, Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis, corticobasal degeneration, Down syndrome, Huntington's Disease |
07/15/2008 | US7399776 Antiinflamamtory agents; immunology disorders; autoimmune diseases; antiallergens; aids viricides; antiarthritic agents; muscular disorders; Parkinson's disease; Alzheimer's disease; kidney damage |
07/15/2008 | US7399775 β-amyloid protein production/secretion inhibitor |
07/15/2008 | US7399774 6-substituted nicotinamide derivatives as opioid receptor antagonists |
07/15/2008 | US7399735 Perfluoropolyether additives |
07/15/2008 | US7399505 Nematic or cholesteric or chiral-smectic; high absolute values of dielectric anisotropy combined with a favorable ratio of viscosity to clearing point; light- and UV-stable, and also thermally stable; high voltage holding ratio |
07/15/2008 | US7399432 Charge transport compositions and electronic devices made with such compositions |
07/15/2008 | US7399320 Dyeing, bleaching keratinous fibers (hair); 2-[5-(N-methyl-2-pyridinylidene)-3-methyl-1-formazano]-N-methylpyridinium chloride |
07/10/2008 | WO2008083054A2 Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure |
07/10/2008 | WO2008082840A1 Pim kinase inhibitors as cancer chemotherapeutics |
07/10/2008 | WO2008082701A1 Method of forming a dry quaternary ammonium salt mixture |
07/10/2008 | WO2008082500A2 Process for the synthesis of 2,6-diaminopyridines from glutarimidines |
07/10/2008 | WO2008082487A2 Novel jnk inhibitors |
07/10/2008 | WO2008081814A1 Method for selective separation of trivalent and tetravalent actinoids from trivalent lanthanoide using hybrid donor-type extracting agent having functional group carrying active oxygen and nitrogen atoms |
07/10/2008 | WO2008081017A1 New n-alkynylcarboxamide derivatives |
07/10/2008 | WO2008080938A1 Use 2-substituted pyridines for cancer treatment |
07/10/2008 | WO2008080511A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
07/10/2008 | WO2008061795A3 N- (methyl) -1h- pyrazol- 3 -amine, n- (methyl) -pyridin-2-amine and n- (methyl) -thiaz0l-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
07/10/2008 | WO2008022046B1 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
07/10/2008 | US20080167474 Effective agents for trapping and indentifying free radical species and find use as efficient antioxidants in physicochemical and biological systems; treatment or prevention of oxidative, ischemic, ischemia/reperfusion-related and chemokine-mediated conditions |
07/10/2008 | US20080167472 Tunable phenylacetylene hosts |
07/10/2008 | US20080167378 For the 14273 peroxisome proliferator activated receptor; antidiabetic agents, hyperlipidemia, obesity or anorexia; receptor binding assay; drug screening kits |
07/10/2008 | US20080167351 Compounds Which Potentiate Glutamate Receptor and Uses Thereof in Medicine |
07/10/2008 | US20080167331 Lowering intraocular pressure; glaucoma |
07/10/2008 | US20080167310 Syndrome X, antidiabetic agents; hypoglycemic agents;antilipemic agents; artherosclerosis; cardiovascular disorders |
07/10/2008 | US20080167307 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof |
07/10/2008 | US20080167306 Novel Heteroaryl Derivative |
07/10/2008 | US20080167300 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases |
07/10/2008 | US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases |
07/10/2008 | US20080167197 Mass labels |
07/10/2008 | US20080166765 Fungal cell wall synthesis gene |
07/10/2008 | US20080166593 Organic Electroluminescent Devices |
07/10/2008 | US20080166299 Prevent accumulation of amyloid deposits |
07/10/2008 | CA2672940A1 Novel jnk inhibitors |
07/09/2008 | EP1942106A1 Therapeutic agents useful for treating pain |
07/09/2008 | EP1942104A1 Heteroarylcyclopropanecarboxamides and their use as pharmaceuticals |
07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
07/09/2008 | EP1940821A2 Novel vanilloid receptor ligands and their use for producing medicaments |
07/09/2008 | EP1940814A1 Piperazine derivatives as antimalarial agents |
07/09/2008 | EP1940813A1 Heterocyclic amide derivatives useful as microbiocides |
07/09/2008 | EP1940792A2 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-1 and/or pim-3 |
07/09/2008 | EP1940791A1 Organic compounds |
07/09/2008 | EP1940786A1 Biphenyl derivatives and their use in treating hepatitis c |
07/09/2008 | EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors |
07/09/2008 | EP1812392B1 Process for preparation of isonicotinic acid derivatives |
07/09/2008 | EP1789041B1 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
07/09/2008 | EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms |
07/09/2008 | EP1474396B9 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
07/09/2008 | EP1465863B1 Potassium channel modulators |
07/09/2008 | EP1421068B1 A process of synthesis of a tricyclic ketone intermediate |
07/09/2008 | EP1303490B1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
07/09/2008 | CN101218237A Oxime derivative and preparations thereof |
07/09/2008 | CN101218206A Histamine H3 receptor antagonists |
07/09/2008 | CN101216668A SBQ aqueous sensitizing powder and its industrial synthesis method |
07/09/2008 | CN101215276A N,N'-substituted phenylpropylamino acid phenylpropylaminoalcohols esters derivatives and preparation method thereof |
07/09/2008 | CN101215261A Method for synthesizing of 2-oxo-3-pyridine formic acid ester and derivatives thereof |
07/09/2008 | CN101215260A Method for preparing benzoylpyridine derivatices and salt thereof |
07/09/2008 | CN101215259A Pyridines derivatives, pharmacological receivable salt thereof, composition containing the said substances and use thereof |
07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
07/09/2008 | CN100400513C Phenylalanine enamide derivatives |
07/09/2008 | CN100400512C Benzoic acid derivatives as modulators of PPAR alpha and gamma |
07/09/2008 | CN100400487C Glucocorticoid receptor modulators |
07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
07/08/2008 | CA2368775C Treatment of cardiovascular and related pathologies |
07/03/2008 | WO2008079924A1 Immune response modifier compositions and methods |
07/03/2008 | WO2008079600A1 Novel intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
07/03/2008 | WO2008079371A1 Modulators of c3a receptor and methods of use thereof |
07/03/2008 | WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure |
07/03/2008 | WO2008078674A1 Glucokinase-activating substance |
07/03/2008 | WO2008077897A1 New products for the treatment of the iron chlorosis |